These results were presented at the San Antonio Breast Cancer Symposium ... affiliations with biotech, pharmaceutical, and/or device companies.
News
- Palbociclib Does Not Improve PFS After Progression on CDK4/6 Inhibitors, ET
- New targeted drug shows benefit against breast cancer in first phase III trial - Labiotech.eu
The findings, presented at the San Antonio Breast Cancer Symposium, establish capivasertib as a potential new treatment for people with estrogen ...
- PreludeDx™ DCISionRT® Data Presented in Spotlight Presentation at the 2022 San ...
The data was presented in a spotlight presentation at the 2022 San Antonio Breast Cancer Symposium (SABCS). Until now, clinicians have relied upon ...
- More breast cancer patients can choose smaller surgery - Medical Xpress
9, 2022, at the San Antonio Breast Cancer Symposium finds many women with two or three breast tumors can get by with lumpectomy surgery instead of ...
- Commentary: Intellectual property erosion threatens economic growth
USAA to leave downtown San Antonio offices by end of year ... Recent reports from the Texas Healthcare and Bioscience Institute show the industry ...